Filing Details

Accession Number:
0001181431-10-052234
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-10-27 17:07:23
Reporting Period:
2010-10-13
Filing Date:
2010-10-27
Accepted Time:
2010-10-27 17:07:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
910267 Titan Pharmaceuticals Inc TTNP.OB Biological Products, (No Disgnostic Substances) (2836) 943171940
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1338543 Friedrich Joachim Kapp 400 Oyster Point Blvd., Suite 505
So. San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-10-13 86,000 $1.43 0 No 4 P Direct
Common Stock Disposition 2010-10-14 181,188 $1.30 0 No 4 P Direct
Common Stock Disposition 2010-10-15 39,460 $1.30 0 No 4 P Direct
Common Stock Disposition 2010-10-18 25,987 $1.30 0 No 4 P Direct
Common Stock Disposition 2010-10-19 14,925 $1.30 0 No 4 P Direct
Common Stock Disposition 2010-10-20 97,700 $1.32 0 No 4 P Direct
Common Stock Disposition 2010-10-21 113,400 $1.31 546,339 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct